Terbinafine hydrochloride is one of 37 small molecule programs targeting Otomycosis. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
76 competitors in Effectiveness
Kesimpta
Mounjaro
Actos
Elucirem
Nicotine Free Cigarettes
Lidocain
Botulinum Toxin a
Pneumococcal Conjugate Vaccine
Gemzar
Droxia
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources